Barrett Katz has sold VRDN and made no open-market buys since Jan 2023
Chief Medical Officer at Viridian Therapeutics, Inc.
SEC CIK 0001841628 · Filings on SEC.gov ↗
$0Bought
$3.2MSold
NoneLast buy
Every filing
2 filings since Jan 2023, newest first
Filings come from SEC EDGAR. Not investment advice.